BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Virol. Sep 25, 2026; 15(3): 121081
Published online Sep 25, 2026. doi: 10.5501/wjv.121081
Table 3 Risk profile of drugs used in inflammatory bowel disease[18,21]
No risk
Low risk
High risk
Highest risk
AminosalicylatesVedolizumabCorticosteroidsTofacitinib (10 mg)
BudesonideUstekinumabAzathioprineUpadacitinib
6-mercaptopurineAnti-TNF + TP
Infliximab3 drug regimens
Adalimumab
Tofacitinib (5 mg)


Write to the Help Desk